Envisioning Post-pandemic Digital Neurological, Psychiatric and Mental Health Care

Frontiers in Digital Health

Graham B. Jones¹  Amit Khanna³ 

[1] Clinical and Translational Science Institute, Tufts University Medical Center, Boston, MA, United States;GDD/TRD Connected Health and Innovation Group, Novartis Pharmaceuticals, East Hanover, NJ, United States;Neuroscience Global Drug Development, Novartis Pharma AG, Basel, Switzerland;

关键词: neurological disease;    psychiatry;    COVID telehealth;    cognitive behavioral therapy;    depression;    multiple sclerosis;   

DOI  :  10.3389/fdgth.2021.803315

来源: DOAJ

【 摘 要 】

The SARS-Cov-2 pandemic placed a dramatic burden on managed healthcare and perhaps nowhere as evident as in neurological and psychiatric disease care. This said, the duration of the pandemic mandated adaptability of the entire care system and the oft-vaunted benefits of telehealth and telemedicine were subjected to deep scrutiny at scale. Positive experiences were reported by both patients and providers from routine check-ups, to use of cognitive behavioral therapy associated with mental disorders, and management of complex diseases such as multiple sclerosis and other neurological and psychiatric conditions. Integration into standard care looks likely in the post pandemic era with many healthcare systems moving to expand reimbursement categories and develop equitable incentive models for developers and providers. In this commentary we share perspective on how the future of care may evolve through hybrid delivery models, and the advent of new therapeutic approaches which can address pain points identified during the pandemic.

【 授权许可】

Unknown